Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats.

Fu Y, Zorman B, Sumazin P, Sanna PP, Repunte-Canonigo V.

PLoS One. 2019 Jan 17;14(1):e0203566. doi: 10.1371/journal.pone.0203566. eCollection 2019.

2.

Diverse reprogramming codes for neuronal identity.

Tsunemoto R, Lee S, Szűcs A, Chubukov P, Sokolova I, Blanchard JW, Eade KT, Bruggemann J, Wu C, Torkamani A, Sanna PP, Baldwin KK.

Nature. 2018 May;557(7705):375-380. doi: 10.1038/s41586-018-0103-5. Epub 2018 May 9.

3.

Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse.

Chen J, Kawamura T, Sethi MK, Zaia J, Repunte-Canonigo V, Sanna PP.

Sci Rep. 2017 Oct 24;7(1):13931. doi: 10.1038/s41598-017-13960-6.

4.

Opiate dependence induces cell type-specific plasticity of intrinsic membrane properties in the rat juxtacapsular bed nucleus of stria terminalis (jcBNST).

Francesconi W, Szücs A, Berton F, Koob GF, Vendruscolo LF, Sanna PP.

Psychopharmacology (Berl). 2017 Dec;234(23-24):3485-3498. doi: 10.1007/s00213-017-4732-4. Epub 2017 Oct 6.

5.

Gene expression patterns associated with neurological disease in human HIV infection.

Sanna PP, Repunte-Canonigo V, Masliah E, Lefebvre C.

PLoS One. 2017 Apr 26;12(4):e0175316. doi: 10.1371/journal.pone.0175316. eCollection 2017.

6.

Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.

Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman RJ, Loring JF.

Brain. 2017 Mar 1;140(3):582-598. doi: 10.1093/brain/aww357.

7.

Translation of BDNF-gene transcripts with short 3' UTR in hippocampal CA1 neurons improves memory formation and enhances synaptic plasticity-relevant signaling pathways.

Wang M, Li D, Yun D, Zhuang Y, Repunte-Canonigo V, Sanna PP, Behnisch T.

Neurobiol Learn Mem. 2017 Feb;138:121-134. doi: 10.1016/j.nlm.2016.07.004. Epub 2016 Jul 6.

PMID:
27394686
8.

11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse.

Sanna PP, Kawamura T, Chen J, Koob GF, Roberts AJ, Vendruscolo LF, Repunte-Canonigo V.

Transl Psychiatry. 2016 Mar 15;6:e760. doi: 10.1038/tp.2016.13.

9.

Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.

Vendruscolo LF, Estey D, Goodell V, Macshane LG, Logrip ML, Schlosburg JE, McGinn MA, Zamora-Martinez ER, Belanoff JK, Hunt HJ, Sanna PP, George O, Koob GF, Edwards S, Mason BJ.

J Clin Invest. 2015 Aug 3;125(8):3193-7. doi: 10.1172/JCI79828. Epub 2015 Jun 29.

10.

Applying the new genomics to alcohol dependence.

Farris SP, Pietrzykowski AZ, Miles MF, O'Brien MA, Sanna PP, Zakhari S, Mayfield RD, Harris RA.

Alcohol. 2015 Dec;49(8):825-36. doi: 10.1016/j.alcohol.2015.03.001. Epub 2015 Mar 28. Review.

11.

Identifying candidate drivers of alcohol dependence-induced excessive drinking by assembly and interrogation of brain-specific regulatory networks.

Repunte-Canonigo V, Shin W, Vendruscolo LF, Lefebvre C, van der Stap L, Kawamura T, Schlosburg JE, Alvarez M, Koob GF, Califano A, Sanna PP.

Genome Biol. 2015 Feb 2;16:68. doi: 10.1186/s13059-015-0593-5.

12.

Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.

Repunte-Canonigo V, Herman M, Kawamura T, Kranzler HR, Sherva R, Gelernter J, Farrer LA, Roberto M, Sanna PP.

Biol Psychiatry. 2015 May 15;77(10):870-879. doi: 10.1016/j.biopsych.2014.07.031. Epub 2014 Aug 19.

13.

Selective conversion of fibroblasts into peripheral sensory neurons.

Blanchard JW, Eade KT, Szűcs A, Lo Sardo V, Tsunemoto RK, Williams D, Sanna PP, Baldwin KK.

Nat Neurosci. 2015 Jan;18(1):25-35. doi: 10.1038/nn.3887. Epub 2014 Nov 24.

14.

VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.

Grieder TE, Herman MA, Contet C, Tan LA, Vargas-Perez H, Cohen A, Chwalek M, Maal-Bared G, Freiling J, Schlosburg JE, Clarke L, Crawford E, Koebel P, Repunte-Canonigo V, Sanna PP, Tapper AR, Roberto M, Kieffer BL, Sawchenko PE, Koob GF, van der Kooy D, George O.

Nat Neurosci. 2014 Dec;17(12):1751-8. doi: 10.1038/nn.3872. Epub 2014 Nov 17.

15.

Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.

Repunte-Canonigo V, Lefebvre C, George O, Kawamura T, Morales M, Koob GF, Califano A, Masliah E, Sanna PP.

Mol Neurodegener. 2014 Jul 1;9:26. doi: 10.1186/1750-1326-9-26.

16.

Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor.

Chen J, Repunte-Canonigo V, Kawamura T, Lefebvre C, Shin W, Howell LL, Hemby SE, Harvey BK, Califano A, Morales M, Koob GF, Sanna PP.

Nat Commun. 2013;4:1955. doi: 10.1038/ncomms2955.

17.

MeCP2 regulates ethanol sensitivity and intake.

Repunte-Canonigo V, Chen J, Lefebvre C, Kawamura T, Kreifeldt M, Basson O, Roberts AJ, Sanna PP.

Addict Biol. 2014 Sep;19(5):791-9. doi: 10.1111/adb.12047. Epub 2013 Feb 28.

18.

Excitability of jcBNST neurons is reduced in alcohol-dependent animals during protracted alcohol withdrawal.

Szücs A, Berton F, Sanna PP, Francesconi W.

PLoS One. 2012;7(8):e42313. doi: 10.1371/journal.pone.0042313. Epub 2012 Aug 21.

19.

Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF.

J Neurosci. 2012 May 30;32(22):7563-71. doi: 10.1523/JNEUROSCI.0069-12.2012.

20.

Gene profiling of laser-microdissected brain regions and individual cells in drug abuse and schizophrenia research.

Sanna PP, Repunte-Canonigo V, Guidotti A.

Methods Mol Biol. 2012;829:541-50. doi: 10.1007/978-1-61779-458-2_34. Review.

PMID:
22231837
21.

Protein degradation by the proteasome is required for synaptic tagging and the heterosynaptic stabilization of hippocampal late-phase long-term potentiation.

Cai F, Frey JU, Sanna PP, Behnisch T.

Neuroscience. 2010 Sep 15;169(4):1520-6. doi: 10.1016/j.neuroscience.2010.06.032. Epub 2010 Jun 22.

PMID:
20600658
22.

Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake.

Repunte-Canonigo V, van der Stap LD, Chen J, Sabino V, Wagner U, Zorrilla EP, Schumann G, Roberts AJ, Sanna PP.

Brain Res. 2010 Jun 21;1339:1-10. doi: 10.1016/j.brainres.2010.03.063. Epub 2010 Apr 10.

23.

A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intake.

Repunte-Canonigo V, Berton F, Cottone P, Reifel-Miller A, Roberts AJ, Morales M, Francesconi W, Sanna PP.

Brain Res. 2010 Jun 21;1339:11-7. doi: 10.1016/j.brainres.2010.03.060. Epub 2010 Apr 7.

24.

Intrinsic neuronal plasticity in the juxtacapsular nucleus of the bed nuclei of the stria terminalis (jcBNST).

Francesconi W, Berton F, Koob GF, Sanna PP.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1347-55. doi: 10.1016/j.pnpbp.2009.08.003. Epub 2009 Aug 12.

25.

Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis.

Francesconi W, Berton F, Repunte-Canonigo V, Hagihara K, Thurbon D, Lekic D, Specio SE, Greenwell TN, Chen SA, Rice KC, Richardson HN, O'Dell LE, Zorrilla EP, Morales M, Koob GF, Sanna PP.

J Neurosci. 2009 Apr 29;29(17):5389-401. doi: 10.1523/JNEUROSCI.5129-08.2009.

26.

A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE Jr, Williamson RA.

J Virol. 2007 Aug;81(15):8315-24. Epub 2007 May 23.

27.

Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats.

Thorsell A, Repunte-Canonigo V, O'Dell LE, Chen SA, King AR, Lekic D, Koob GF, Sanna PP.

Brain. 2007 May;130(Pt 5):1330-7. Epub 2007 Apr 2.

28.

Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure.

Repunte-Canonigo V, Lutjens R, van der Stap LD, Sanna PP.

Brain Res. 2007 Mar 23;1138:48-56. Epub 2007 Jan 30.

29.

Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.

Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T.

Mol Psychiatry. 2007 Feb;12(2):167-89. Epub 2006 Oct 10.

PMID:
17033635
30.
31.

Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction.

Ahmed SH, Lutjens R, van der Stap LD, Lekic D, Romano-Spica V, Morales M, Koob GF, Repunte-Canonigo V, Sanna PP.

Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11533-8. Epub 2005 Aug 2.

32.

Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.

Izzo E, Sanna PP, Koob GF.

Pharmacol Biochem Behav. 2005 Aug;81(4):701-8.

PMID:
16005056
33.

Gene profiling of laser-microdissected brain regions and sub-regions.

Sanna PP, King AR, van der Stap LD, Repunte-Canonigo V.

Brain Res Brain Res Protoc. 2005 Jul;15(2):66-74.

PMID:
15946894
34.

Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity.

Conti B, Sugama S, Lucero J, Winsky-Sommerer R, Wirz SA, Maher P, Andrews Z, Barr AM, Morale MC, Paneda C, Pemberton J, Gaidarova S, Behrens MM, Beal F, Sanna PP, Horvath T, Bartfai T.

J Neurochem. 2005 Apr;93(2):493-501.

35.

The metabotropic glutamate receptor 5 is necessary for late-phase long-term potentiation in the hippocampal CA1 region.

Francesconi W, Cammalleri M, Sanna PP.

Brain Res. 2004 Oct 1;1022(1-2):12-8.

PMID:
15353208
36.

HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region.

Behnisch T, Francesconi W, Sanna PP.

Brain Res. 2004 Jun 25;1012(1-2):187-9.

PMID:
15158177
37.

Cocaine's long run.

Sanna PP, Koob GF.

Nat Med. 2004 Apr;10(4):340-1. No abstract available.

PMID:
15057223
38.

Neurobiological mechanisms in the transition from drug use to drug dependence.

Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O'Dell LE, Parsons LH, Sanna PP.

Neurosci Biobehav Rev. 2004 Jan;27(8):739-49. Review.

PMID:
15019424
39.

Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1.

Cammalleri M, Lütjens R, Berton F, King AR, Simpson C, Francesconi W, Sanna PP.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14368-73. Epub 2003 Nov 17.

40.

The transient depression of hippocampal CA1 LTP induced by chronic intermittent ethanol exposure is associated with an inhibition of the MAP kinase pathway.

Roberto M, Nelson TE, Ur CL, Brunelli M, Sanna PP, Gruol DL.

Eur J Neurosci. 2003 Apr;17(8):1646-54.

PMID:
12752382
41.

Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization.

Izzo E, Martin-Fardon R, Koob GF, Weiss F, Sanna PP.

Nat Neurosci. 2002 Dec;5(12):1263-4.

PMID:
12436114
42.

ERK regulation in chronic ethanol exposure and withdrawal.

Sanna PP, Simpson C, Lutjens R, Koob G.

Brain Res. 2002 Sep 6;948(1-2):186-91.

PMID:
12383974
43.

Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region.

Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, Francesconi W.

J Neurosci. 2002 May 1;22(9):3359-65. Erratum in: J Neurosci 2002 Dec 1;22(23):10507.

44.

Expression of antibody Fab fragments and whole immunoglobulin in mammalian cells.

Sanna PP.

Methods Mol Biol. 2002;178:389-95. Review. No abstract available.

PMID:
11968508
45.

Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase.

Díaz-Ruiz O, Navarro L, Méndez-Díaz M, Galicia O, Elder JH, Sanna PP, Drucker-Colín R, Prospéro-García O.

Brain Res. 2001 Sep 14;913(1):78-81.

PMID:
11532249
47.

Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.

Williamson RA, Burgoon MP, Owens GP, Ghausi O, Leclerc E, Firme L, Carlson S, Corboy J, Parren PW, Sanna PP, Gilden DH, Burton DR.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1793-8. Epub 2001 Feb 6.

48.

Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA.

Rende M, Brizi E, Conner J, Treves S, Censier K, Provenzano C, Taglialatela G, Sanna PP, Donato R.

Int J Dev Neurosci. 2000 Dec;18(8):869-85.

PMID:
11154856
49.

Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Sanna PP, Burton DR.

J Virol. 2000 Nov;74(21):9813-7. Review. No abstract available.

50.

Effect of nociceptin/orphanin FQ on the rewarding properties of morphine.

Ciccocioppo R, Angeletti S, Sanna PP, Weiss F, Massi M.

Eur J Pharmacol. 2000 Sep 15;404(1-2):153-9.

PMID:
10980274

Supplemental Content

Loading ...
Support Center